Elyse A. Olesinski, MPH

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Bhatia K, Mahesh A, Olesinski E, Garcia J, Jain N, Jen WY, Ming MOG, Letai A, Konopleva M, Bhatt S. Proceedings of the European Hematology Association 2022 Hybrid Congress. BH3 profiling identifies selective BCL-2 dependence of adult early T-cell progenitor and typical acute lymphoblastic leukemia patients. 2022.
  2. Olesinski EA, Bhatt S. Dynamic BH3 profiling method for rapid identification of active therapy in BH3 mimetics resistant xenograft mouse models. STAR Protoc. 2021 06 18; 2(2):100461. PMID: 34027474; PMCID: PMC8131978; DOI: 10.1016/j.xpro.2021.100461;
     
  3. Bhatt S, Piosos MS, Olesinski EA, Yilma BG, Ryan JA, Mashaka T, Leutz B, Adamia S, Weinstock DM, Garcia JS, Letai A. Proceedings of the American Association for Cancer Research Annual Meeting 2021. Reduction in mitochondrial priming drives resistance to targeted therapy in acute myeloid leukemia. 2021.
  4. Bhatt S, Pioso MS, Olesinski EA, Yilma B, Ryan JA, Mashaka T, Leutz B, Adamia S, Zhu H, Kuang Y, Mogili A, Louissaint A, Bohl SR, Kim AS, Mehta AK, Sanghavi S, Wang Y, Morris E, Halilovic E, Paweletz CP, Weinstock DM, Garcia JS, Letai A. Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia. Cancer Cell. 2020 12 14; 38(6):872-890.e6. PMID: 33217342; PMCID: PMC7988687; DOI: 10.1016/j.ccell.2020.10.010;
     
  5. Bhatt S, Pioso M, Olesinski EA, Yilma B, Buon L, Adamia S, Zhu H, Ryan J, Wang Y, Erick M, Halilovic E, Weinstock DM, Garcia JS, Letai A. Individualized Mitochondrial Functional Approach to Combination of BCL-2 and MCL-1 Antagonism in Acute Myeloid Leukemia. American Society of Hematology. 2019.
  6. Sperling AS, Burgess M, Keshishian H, Gasser JA, Bhatt S, Jan M, Slabicki M, Sellar RS, Fink EC, Miller PG, Liddicoat BJ, Sievers QL, Sharma R, Adams DN, Olesinski EA, Fulciniti M, Udeshi ND, Kuhn E, Letai A, Munshi NC, Carr SA, Ebert BL. Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs. Blood. 2019 07 11; 134(2):160-170.View Related Profiles. PMID: 31043423; PMCID: PMC6624968; DOI: 10.1182/blood.2019000789;
     
  7. Bhatt S, Yilma B, Olesinski E, Zhu H, Murakami M, Murali VM, Adamia S, Weinstock DM, Garcia JS, Letai A. Proceedings of the American Association for Cancer Research Annual Meeting 2019. Individualized functional approach to tailoring acute myeloid leukemia therapy. 2019.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 7 publications over 4 distinct years, with a maximum of 3 publications in 2019

YearPublications
20193
20201
20212
20221


2022 Karin Grunebaum Cancer Research Foundation: Karin Grunebaum Summer Research Fellowship
2022 Boston University School of Medicine: Medical Student Summer Research Program
2020 Boston University School of Public Health: Practicum Scholar Award
2018 Boston University: Yawkey Foundation Nonprofit Internship Program
Contact for Mentoring:

Olesinski's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_